专利检索 ap:("Aventis Pharma Deutschland GmbH") AND inv:"JUNG, Oliver" 第 1 页

1.

发明授权
VERWENDUNG VON INHIBITOREN DES ZELLULÄREN Na+ /H+ -EXCHANGERS (NHE) ZUR HERSTELLUNG EINES MEDIKAMENTS ZUR NORMALISIERUNG DER SERUMLIPIDE 失效
标题翻译：作者细胞Na + / H + -EXCHANGERS（NHE）抑制剂用于生产一种药物，用于归一化血清脂质USE

公开(公告)号：EP0918515B1

公开(公告)日：2005-04-27

申请号：EP97923937.3

申请日：1997-05-20

申请人： Aventis Pharma Deutschland GmbH

发明人： LANG, Hans, Jochen , JANSEN, Hans-Willi , SCHWARK, Jan-Robert , KLEEMANN, Heinz-Werner , JUNG, Oliver , SCHÄFER, Hans-Ludwig , LINZ, Wolfgang , KRAMER, Werner , SCHÖLKENS, Bernward , FALK, Eugen

IPC分类号： A61K31/155 , A61K31/455 , A61K31/22 , A61K45/00 , A61K45/06 , A61P3/06

CPC分类号： A61K31/166 , A61K31/00 , A61K31/155 , A61K31/22 , A61K31/365 , A61K31/165 , A61K2300/00

摘要： The active substances identified as inhibitors of the cellular Na+/H+ exchanger (NHE) are used to prepare a medicament for normalizing serum lipids. They are used in the preparation of a medicament which reduces lipid levels in the blood and can be administered for treating diseases caused by lipid levels which are too high, and for alleviating the endothelial dysfunctional syndrome and for treating diseases caused thereby.